N-[[3-(Aminomethyl)phenyl]methyl]ethanimidamide
CAS: 180001-34-7
Ref. 3D-FHA00134
1mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
250mg | Ausgelaufen | ||
2500mg | Ausgelaufen |
Produktinformation
- (1E)-N'-[3-(aminomethyl)benzyl]ethanimidamide dihydrochloride
- 1400W
- 1400W94
- Ethanimidamide, N-[[3-(aminomethyl)phenyl]methyl]-
- W 1400
- N-[3-(Aminomethyl)benzyl]acetamidine
N-[[3-(Aminomethyl)phenyl]methyl]ethanimidamide is an inhibitor analog with potent anticancer properties. It has been shown to inhibit the activity of kinases, which are enzymes that play a critical role in cell growth and division. This compound is derived from indirubin, a traditional Chinese medicine used for the treatment of cancer. N-[[3-(Aminomethyl)phenyl]methyl]ethanimidamide induces apoptosis in cancer cells and prevents tumor growth by inhibiting protein synthesis. Additionally, this compound has been detected in human urine and may have potential as a biomarker for cancer diagnosis and monitoring. Overall, N-[[3-(Aminomethyl)phenyl]methyl]ethanimidamide shows promising potential as an effective anticancer agent.